ID
36155
Beschrijving
Evaluating the Effectiveness of Neupro® (Rotigotine) and L-dopa Combination Therapy in Patients With Parkinson's Disease; ODM derived from: https://clinicaltrials.gov/show/NCT02227355
Link
https://clinicaltrials.gov/show/NCT02227355
Trefwoorden
Versies (1)
- 18-04-19 18-04-19 -
Houder van rechten
See clinicaltrials.gov
Geüploaded op
18 april 2019
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Idiopathic Parkinson's Disease NCT02227355
Eligibility Idiopathic Parkinson's Disease NCT02227355
- StudyEvent: Eligibility
Beschrijving
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Beschrijving
Study Subject Participation Status | Investigational New Drugs | Investigational Medical Device
Datatype
boolean
Alias
- UMLS CUI [1]
- C2348568
- UMLS CUI [2]
- C0013230
- UMLS CUI [3]
- C2346570
Similar models
Eligibility Idiopathic Parkinson's Disease NCT02227355
- StudyEvent: Eligibility
C1550543 (UMLS CUI [1,2])
C1700683 (UMLS CUI [1,2])
C2348814 (UMLS CUI [1,3])
C1744706 (UMLS CUI [2,1])
C0178601 (UMLS CUI [2,2])
C0205394 (UMLS CUI [2,3])
C0235828 (UMLS CUI [3,1])
C0178601 (UMLS CUI [3,2])
C0205394 (UMLS CUI [3,3])
C0021430 (UMLS CUI [2,1])
C0030701 (UMLS CUI [2,2])
C1700683 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C0679823 (UMLS CUI [3,1])
C0034394 (UMLS CUI [3,2])
C0009429 (UMLS CUI [2])
C0178601 (UMLS CUI [3])
C1705847 (UMLS CUI [4,1])
C1700683 (UMLS CUI [4,2])
C1704632 (UMLS CUI [2])
C0013230 (UMLS CUI [2])
C2346570 (UMLS CUI [3])